Literature DB >> 16707553

Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway".

Joel Linden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16707553     DOI： 10.1152/ajpcell.00242.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN： 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  11 in total

Review 1.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

2.  Host A(2B) adenosine receptors promote carcinoma growth.

Authors:  Sergey Ryzhov; Sergey V Novitskiy; Rinat Zaynagetdinov; Anna E Goldstein; David P Carbone; Italo Biaggioni; Mikhail M Dikov; Igor Feoktistov
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

Review 3.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

Review 4.  Immunity, inflammation and cancer: a leading role for adenosine.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Nat Rev Cancer       Date:  2013-11-14       Impact factor: 60.716

5.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

6.  CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Miroslaw Szczepanski; Malgorzata Harasymczuk; Jin Ren; Dongmei Cheng; Edwin K Jackson; Elieser Gorelik; Jonas Johnson; Stephan Lang; Theresa L Whiteside
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

Review 7.  The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia.

Authors:  Vanessa D'Antongiovanni; Matteo Fornai; Carolina Pellegrini; Laura Benvenuti; Corrado Blandizzi; Luca Antonioli
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

8.  Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells.

Authors:  Beatris Mastelic-Gavillet; Blanca Navarro Rodrigo; Laure Décombaz; Haiping Wang; Giuseppe Ercolano; Rita Ahmed; Leyder Elena Lozano; Angela Ianaro; Laurent Derré; Massimo Valerio; Thomas Tawadros; Patrice Jichlinski; Tu Nguyen-Ngoc; Daniel E Speiser; Grégory Verdeil; Nicolas Gestermann; Olivier Dormond; Lana Kandalaft; George Coukos; Camilla Jandus; Christine Ménétrier-Caux; Christophe Caux; Ping-Chih Ho; Pedro Romero; Alexandre Harari; Selena Vigano
Journal:  J Immunother Cancer       Date:  2019-10-10       Impact factor: 13.751

9.  Purine-metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells.

Authors:  Fariborz Bahrami; Filip Kukulski; Joanna Lecka; Alain Tremblay; Julie Pelletier; Liliana Rockenbach; Jean Sévigny
Journal:  Mediators Inflamm       Date:  2014-07-23       Impact factor: 4.711

Review 10.  Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?

Authors:  Tiziana Vaisitti; Francesca Arruga; Silvia Deaglio
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.